Tag: Chemotherapy
Tislelizumab Plus Chemotherapy Beneficial for Resectable NSCLC
Significant benefit seen for neoadjuvant tislelizumab plus chemotherapy with adjuvant tislelizumab
Pegargiminase + Chemo Increases Survival Rate in Nonepithelioid Pleural Mesothelioma
Improved median overall survival and progression-free survival seen for pegargiminase-based chemotherapy
Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy
Race Can Affect Breast Cancer Test for Predicting Chemo Benefit
21-gene recurrence score may underestimate benefit of chemotherapy for young non-Hispanic Black women with ER-positive, axillary node-negative breast cancer
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Chemoradiation With SABR Boost Safe, Effective for Advanced Lung Cancer
Increased radiation with SABR boost seems to enhance local control but with reduced overall survival at highest dose
SABCS: Neoadjuvant Chemo Can Let Breast Cancer Patients Skip Nodal RT
Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
